Cancer-related inflammation
Open accessThe DOI matches its Crossref record; 174 of the 175 references it cites were found in a registry or an index.
Abstract
The mediators and cellular effectors of inflammation are important constituents of the local environment of tumours. In some types of cancer, inflammatory conditions are present before a malignant change occurs. Conversely, in other types of cancer, an oncogenic change induces an inflammatory microenvironment that promotes the development of tumours. Regardless of its origin, 'smouldering' inflammation in the tumour microenvironment has many tumour-promoting effects. It aids in the proliferation and survival of malignant cells, promotes angiogenesis and metastasis, subverts adaptive immune responses, and alters responses to hormones and chemotherapeutic agents. The molecular pathways of this cancer-related inflammation are now being unravelled, resulting in the identification of new target molecules that could lead to improved diagnosis and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“many of these processes also occur in cancer as most of them are inflammation-related, including hypoxia-induced neovascularization, endothelial dysfunction, permeability of the microvasculature and the upregulation of adhesion molecules to facilitate the recruitment of cells30,31.”
From Perspectives and opportunities for nanomedicine in the management of atherosclerosis (2011) · cites this paper as [31]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“On the other hand, cytokine production can be triggered by oncogenic transformation, metabolic alteration, cell death, hypoxia, and the use of anti-cancer drugs (10).”
From Tumor-Induced Inflammatory Cytokines and the Emerging Diagnostic Devices for Cancer Detection and Prognosis (2021) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Besides promoting cell proliferation, the action of cytokines in promoting cancer development includes antagonizing anti-tumor immune response, recruiting tumor-supportive stromal cells and immune-suppressive cells, inducing angiogenesis and metastasis, and altering the responses to therapeutic agents (10, 15)”
From Tumor-Induced Inflammatory Cytokines and the Emerging Diagnostic Devices for Cancer Detection and Prognosis (2021) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Excessive or dysregulated inflammation is a major driver of tissue damage and the pathogenesis of numerous diseases, including stroke, Parkinson’s disease, atherosclerosis, and cancer [9,30,31,32,33].”
From Picroside II as a Potential Anti-Inflammatory Agent (2026) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Therefore, rather than the dogma that oncogenesis is intrinsically triggered in pre-neoplastic cells, environmental factors, such as infection, stress, obesity, aging and smoking, each of which can induce chronic inflammation, could be a major cause of oncogenesis (4, 6, 9, 233).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [6]
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746 · cited 1×
“jpg" NDATA ITEM> ]> Links between cancer and inflammation were first made in the nineteenth century, on the basis of observations that tumours often arose at sites of chronic inflammation and that inflammatory cells were present in biopsied samples from tumour”
Self-citationMANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 1×
“TAMs and related cell types in mouse and human tumours generally have an M2 phenotype, which is oriented towards promoting tumour growth, remodelling tissues, promoting angiogenesis and suppressing adaptive immunity&hairsp”
Self-citationInvolvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056 · cited 1×
“This type of response might also contribute to successful chemotherapy or radiotherapy, according to recent data obtained by Lionel Apetoh and colleague”
The Immunobiology of Cancer Immunosurveillance and Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.017 · Cited by 3,032 · cited 1×
“Cancer-related inflammation and adaptive immunity There is strong evidence from genetic studies of mouse models that cells of the adaptive immune system carry out surveillance and can eliminate nascent tumours (a process called immuno-editing”
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790 · cited 1×
“This transcription factor is constitutively activated both in tumour cells and in immune cells, and is involved in oncogenesis and inhibition of apoptosi”
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695 · cited 1×
“TAMs have been described as “obligate partners for tumour-cell migration, invasion and metastasis&rdquo”
Cited by
Items 801–900 of 1,085
Inflammatory burden as a prognostic biomarker for cancer
Xie, H., Ruan, G., Ge, Y., Zhang, Q., Zhang, H., Lin, S., Song, M., Zhang, X., Liu, X., Li, X., et al. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.04.019 · Cited by 169
Tracking of intertissue migration reveals the origins of tumor-infiltrating monocytes
Shand, F. H. W., Ueha, S., Otsuji, M., Koid, S. S., Shichino, S., Tsukui, T., Kosugi-Kanaya, M., Abe, J., Tomura, M., Ziogas, J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402914111 · Cited by 175
Linhart, K., Bartsch, H., & Seitz, H. K. (2014) · Redox Biology · doi:10.1016/j.redox.2014.08.009 · Cited by 180
“…of Alcohol Research, University of Heidelberg, Heidelberg, Germany b Department of Medicine (Gastroenterology & Hepatology), Salem Medical Centre, Heidelberg, Germany c Division of Toxicology and Cancer Risk Factors, German Cancer Research Centre (DKFZ), Heidelberg, Germany a r t i c l e i n f o”
BackgroundRacial Differences in Cancer Susceptibility and Survival: More Than the Color of the Skin?
Özdemir, B. C., & Dotto, G.-P. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2017.02.002 · Cited by 178
“About 15–20% of cancerrelated deaths are thought to be due to underlying infections and associated inflammatory responses [57].”
BackgroundJomrich, G., Paireder, M., Kristo, I., Baierl, A., Ilhan-Mutlu, A., Preusser, M., Asari, R., & Schoppmann, S. F. (2021) · Annals of Surgery · doi:10.1097/sla.0000000000003370 · Cited by 176
“There are increasing data showing that inflammation is closely connected with tumorigenesis, tumor progression, and metastasis.(1,2,16) The prognostic significance of inflammation-based biomarkers and scores has recently been shown in a number of solid tumors, including EC, whereas none of the studies used clinical fa…”
BackgroundProgress on Modulating Tumor‐Associated Macrophages with Biomaterials
Sylvestre, M., Crane, C. A., & Pun, S. H. (2020) · Advanced Materials · doi:10.1002/adma.201902007 · Cited by 180
Current Advances of Nitric Oxide in Cancer and Anticancer Therapeutics
Mintz, J., Vedenko, A., Rosete, O., Shah, K., Goldstein, G., Hare, J. M., Ramasamy, R., & Arora, H. (2021) · Vaccines · doi:10.3390/vaccines9020094 · Cited by 180
“Aside from their NO-producing ability, macrophages are among the most prominent immune cells in the TME, as they are able to infiltrate deep into the tumor and can account for almost 50% of the tumor mass [91,97].”
BackgroundBioactive Peptides and Hydrolysates from Pulses and Their Potential Use as Functional Ingredients
López‐Barrios, L., Gutiérrez‐Uribe, J. A., & Serna‐Saldívar, S. O. (2014) · Journal of Food Science · doi:10.1111/1750-3841.12365 · Cited by 178
Severi, T., van Malenstein, H., Verslype, C., & van Pelt, J. F. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.142 · Cited by 177
Molecular pathways and targets in cancer-related inflammation
Mantovani, A., Garlanda, C., & Allavena, P. (2010) · Annals of Medicine · doi:10.3109/07853890903405753 · Cited by 185
Self-citationNuclear receptor NR4A1 promotes breast cancer invasion and metastasis by activating TGF-β signalling
Zhou, F., Drabsch, Y., Dekker, T. J. A., de Vinuesa, A. G., Li, Y., Hawinkels, L. J. A. C., Sheppard, K.-A., Goumans, M.-J., Luwor, R. B., de Vries, C. J., et al. (2014) · Nature Communications · doi:10.1038/ncomms4388 · Cited by 180
Clements, V. K., Long, T., Long, R., Figley, C., Smith, D. M. C., & Ostrand-Rosenberg, S. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.4hi0517-210r · Cited by 171
Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies
Gelfo, V., Romaniello, D., Mazzeschi, M., Sgarzi, M., Grilli, G., Morselli, A., Manzan, B., Rihawi, K., & Lauriola, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176009 · Cited by 175
“A causal relation between inflammation and cancer has been proposed by Virchow in 1863, who hypothesized that malignant neoplasms arise within a region of chronic inflammation causing tissue injuries and increased cell growth [1].”
BackgroundModes of invasion during tumour dissemination
Pandya, P., Orgaz, J. L., & Sanz‐Moreno, V. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12019 · Cited by 174
“As noted earlier, ECM degradation and tissue remodelling by secreted proteases regulate invasion (Friedl and Alexander, 2011; Mantovani et al., 2008).”
BackgroundPrognostic significance of lymphocyte to monocyte ratio in colorectal cancer: A meta-analysis
Tan, D., Fu, Y., Tong, W., & Li, F. (2018) · International Journal of Surgery · doi:10.1016/j.ijsu.2018.05.030 · Cited by 178
Sideras, K., Braat, H., Kwekkeboom, J., van Eijck, C. H., Peppelenbosch, M. P., Sleijfer, S., & Bruno, M. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.11.005 · Cited by 173
“It is now known that both the innate and the adaptive immune system are active against human cancers [2].”
BackgroundObesity and colorectal cancer: molecular features of adipose tissue
Martinez-Useros, J., & Garcia-Foncillas, J. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0772-5 · Cited by 167
Ma, S., Song, W., Xu, Y., Si, X., Lv, S., Zhang, Y., Tang, Z., & Chen, X. (2020) · Nano Letters · doi:10.1021/acs.nanolett.9b05265 · Cited by 178
Mitogen-activated protein kinases in hepatocellular carcinoma development
Min, L., He, B., & Hui, L. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.10.011 · Cited by 178
Carbon Nanotubes Elicit DNA Damage and Inflammatory Response Relative to Their Size and Shape
Yamashita, K., Yoshioka, Y., Higashisaka, K., Morishita, Y., Yoshida, T., Fujimura, M., Kayamuro, H., Nabeshi, H., Yamashita, T., Nagano, K., et al. (2010) · Inflammation · doi:10.1007/s10753-010-9182-7 · Cited by 174
“During tumor promotion, inflammatory cells produce cytokines and chemokines, which facilitate cancer cell survival, proliferation, and promote the angiogenic switch, resulting in increased tumor growth [ 20 ].”
BackgroundOxidative and nitrative DNA damage: Key events in opisthorchiasis-induced carcinogenesis
Yongvanit, P., Pinlaor, S., & Bartsch, H. (2012) · Parasitology International · doi:10.1016/j.parint.2011.06.011 · Cited by 175
Transcriptional mechanisms of WNT5A based on NF-κB, Hedgehog, TGFβ, and Notch signaling cascades
Katoh (2009) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000190 · Cited by 174
Zhang, J., Zhang, H.-Y., Li, J., Shao, X.-Y., & Zhang, C.-X. (2017) · Oncotarget · doi:10.18632/oncotarget.18575 · Cited by 178
“The colorectal cancer (CRC) is one of the increasingly common malignancies worldwide.”
BackgroundInfluentialThe anti-cancer effects and mechanisms of lactic acid bacteria exopolysaccharides in vitro: A review
Wu, J., Zhang, Y., Ye, L., & Wang, C. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.117308 · Cited by 172
Zhang, F., Ma, Y., Li, D., Wei, J., Chen, K., Zhang, E., Liu, G., Chu, X., Liu, X., Liu, W., et al. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01600-2 · Cited by 212
González, N., Diabetes Cancer Connect Consortium, Prieto, I., del Puerto-Nevado, L., Portal-Nuñez, S., Ardura, J. A., Corton, M., Fernández-Fernández, B., Aguilera, O., Gomez-Guerrero, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14472 · Cited by 168
Elevated neutrophil-to-lymphocyte ratio in the diagnosis of Hashimoto's thyroiditis
Aktas, G., Sit, M., Dikbas, O., Erkol, H., Altinordu, R., Erkus, E., & Savli, H. (2017) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.63.12.1065 · Cited by 173
Diagnostic Sensitivity of NLR and PLR in Early Diagnosis of Gastric Cancer
Fang, T., Wang, Y., Yin, X., Zhai, Z., Zhang, Y., Yang, Y., You, Q., Li, Z., Ma, Y., Li, C., et al. (2020) · Journal of Immunology Research · doi:10.1155/2020/9146042 · Cited by 178
Inflammatory Mediators and Pain in Endometriosis: A Systematic Review
Machairiotis, N., Vasilakaki, S., & Thomakos, N. (2021) · Biomedicines · doi:10.3390/biomedicines9010054 · Cited by 164
“This forms a microenvironment that contributes to the development of the ectopic endometrial tissue by facilitating localized angiogenesis and disrupting the normal apoptotic processes [5].”
BackgroundHuang, D., Sun, L., Huang, L., & Chen, Y. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11020124 · Cited by 176
The multifaceted regulation and functions of PKM2 in tumor progression
Li, Z., Yang, P., & Li, Z. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.07.008 · Cited by 175
The Role of Interleukin 17 in Tumour Proliferation, Angiogenesis, and Metastasis
Yang, B., Kang, H., Fung, A., Zhao, H., Wang, T., & Ma, D. (2014) · Mediators of Inflammation · doi:10.1155/2014/623759 · Cited by 169
“It is a crucial part of the tumour microenvironment [57] and the literature so seems to map out more pathways of Th17-mediated angiogenesis [25, 27, 33, 51, 57–91] than it does for its inhibition [64, 79, 80, 92–98].”
BackgroundÅlgars, A., Irjala, H., Vaittinen, S., Huhtinen, H., Sundström, J., Salmi, M., Ristamäki, R., & Jalkanen, S. (2012) · International Journal of Cancer · doi:10.1002/ijc.26457 · Cited by 167
Na, Y.-R., Yoon, Y.-N., Son, D.-I., & Seok, S.-H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063451 · Cited by 172
“Indeed, M2-macrophages differentiate from monocytes in response to specific growth factors released by both malignant and stromal tumor compartments, including CCL2, MCSF, vascular endothelial growth factor (VEGF) and CXCL12 (also known as SDF1) [2,15,16].”
BackgroundBauer, I., Grozio, A., Lasigliè, D., Basile, G., Sturla, L., Magnone, M., Sociali, G., Soncini, D., Caffa, I., Poggi, A., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.405837 · Cited by 177
“In addition, even in those cancers that do not develop in inflamed tissues, an inflammatory component is usually observed, and it is now known to be an essential part of the malignant microenvironment (2, 3).”
BackgroundMacrophage regulation of tumor angiogenesis: Implications for cancer therapy
Squadrito, M. L., & De Palma, M. (2011) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.04.005 · Cited by 170
The controversial role of Enterococcus faecalis in colorectal cancer
de Almeida, C. V., Taddei, A., & Amedei, A. (2018) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284818783606 · Cited by 164
Sleep disturbance, inflammation and depression risk in cancer survivors
Irwin, M. R., Olmstead, R. E., Ganz, P. A., & Haque, R. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.05.002 · Cited by 173
“sponses are linked to 15–20% of all deaths from cancer worldwide (Mantovani et al., 2008).”
BackgroundPain, Depression, and Fatigue as a Symptom Cluster in Advanced Cancer
Laird, B. J. A., Scott, A. C., Colvin, L. A., McKeon, A.-L., Murray, G. D., Fearon, K. C. H., & Fallon, M. T. (2011) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2010.10.261 · Cited by 170
Tumour-associated macrophages and cancer
Cook, J., & Hagemann, T. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.05.017 · Cited by 165
“The complex balance between protumoural and anti-tumoural effects of immune cell infiltration is thought to create a chronic inflammatory microenvironment essential for tumour growth, progression and invasion [4,5,6 ,7,8].”
BackgroundBakiri, L., & Wagner, E. F. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.01.005 · Cited by 172
“A role for inflammation in tumor development is now generally accepted and an inflammatory environment appears to be an essential component of all tumors, including those, where a direct causal relationship with inflammation is not yet proven (DiDonato et al., 2012; Mantovani et al., 2008).”
BackgroundFlavonoids and Phenolic Compounds from Rosmarinus officinalis
Bai, N., He, K., Roller, M., Lai, C.-S., Shao, X., Pan, M.-H., & Ho, C.-T. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf100332w · Cited by 167
Allavena, P., Chieppa, M., Bianchi, G., Solinas, G., Fabbri, M., Laskarin, G., & Mantovani, A. (2010) · Journal of Immunology Research · doi:10.1155/2010/547179 · Cited by 170
Self-citationPromoting effect of neutrophils on lung tumorigenesis is mediated by CXCR2 and neutrophil elastase
Gong, L., Cumpian, A. M., Caetano, M. S., Ochoa, C. E., De la Garza, M. M., Lapid, D. J., Mirabolfathinejad, S. G., Dickey, B. F., Zhou, Q., & Moghaddam, S. J. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-154 · Cited by 150
“According to epidemiological studies, up to 20% of cancers are linked to chronic infections and inflammation [31].”
Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation
Geskin, L. J., Viragova, S., Stolz, D. B., & Fuschiotti, P. (2015) · Blood · doi:10.1182/blood-2014-07-590398 · Cited by 166
Mohd Bakri, M., Mohd Hussaini, H., Rachel Holmes, A., David Cannon, R., & Mary Rich, A. (2010) · Journal of Oral Microbiology · doi:10.3402/jom.v2i0.5780 · Cited by 168
Huo, C. W., Chew, G., Hill, P., Huang, D., Ingman, W., Hodson, L., Brown, K. A., Magenau, A., Allam, A. H., McGhee, E., et al. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0592-1 · Cited by 168
“Interestingly, where local inflammation remains chronic, such as in cases of inflammatory bowel disease or chronic Helicobacter pylori infection of the stomach, the frequency of cancer is also increased [106].”
BackgroundThe Relationship Between Dormant Cancer Cells and Their Microenvironment
(2016) · Advances in Cancer Research · doi:10.1016/bs.acr.2016.07.002 · Cited by 162
IGFBP2: integrative hub of developmental and oncogenic signaling network
Li, T., Forbes, M. E., Fuller, G. N., Li, J., Yang, X., & Zhang, W. (2020) · Oncogene · doi:10.1038/s41388-020-1154-2 · Cited by 175
Transcription Factors in Cancer Development and Therapy
Vishnoi, K., Viswakarma, N., Rana, A., & Rana, B. (2020) · Cancers · doi:10.3390/cancers12082296 · Cited by 164
“STAT3 plays a very crucial role in the initiation and progression of cancer by promoting a pro-carcinogenic inflammatory microenvironment [30,31], while suppressing anti-tumor immunity [32].”
BackgroundNeutrophils—From Bone Marrow to First-Line Defense of the Innate Immune System
Kraus, R. F., & Gruber, M. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.767175 · Cited by 192
“Cancer presents with inflammation, and inflammatory response is an important factor for the development of tumors (213, 352).”
BackgroundMetabolism drives macrophage heterogeneity in the tumor microenvironment
Li, S., Yu, J., Huber, A., Kryczek, I., Wang, Z., Jiang, L., Li, X., Du, W., Li, G., Wei, S., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110609 · Cited by 164
“TAMs are associated with multiple aspects of tumor pathobiology, such as immunosuppression, neovascularization, metastasis, and resistance to therapy (Ding et al., 2009; Forssell et al., 2007; Mantovani et al., 2008; Qian and Pollard, 2010; Ruffell et al., 2012; Sica and Mantovani, 2012; Zou, 2005).”
BackgroundPadinharayil, H., Varghese, J., John, M. C., Rajanikant, G. K., Wilson, C. M., Al-Yozbaki, M., Renu, K., Dewanjee, S., Sanyal, R., Dey, A., et al. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2022.07.023 · Cited by 159
Chapter 10 The Cancer Cell–Leukocyte Fusion Theory of Metastasis
(2008) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)00410-7 · Cited by 166
A Review of the Application of Inflammatory Biomarkers in Epidemiologic Cancer Research
Brenner, D. R., Scherer, D., Muir, K., Schildkraut, J., Boffetta, P., Spitz, M. R., Le Marchand, L., Chan, A. T., Goode, E. L., Ulrich, C. M., et al. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0064 · Cited by 162
“Methodologic issues in epidemiologic studies on inflammation and cancer In the evaluation of the associations between inflammation and cancer risk, careful consideration must be taken to address the potential for biased associations due to the well-known proinflammatory potential of tumors and, thus, theirmicroenviron…”
Borsig, L. (2018) · Glycobiology · doi:10.1093/glycob/cwx105 · Cited by 167
“L-selectin modulate adaptive and innate immunity in cancer The capacity of leukocyte to either promote or control cancer progression largely depends on spatial and temporal stimulation of the tumor microenvironment (Coussens and Werb 2002, Mantovani et al. 2008).”
Jomrich, G., Gruber, E. S., Winkler, D., Hollenstein, M., Gnant, M., Sahora, K., & Schindl, M. (2020) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-019-04187-z · Cited by 166
Rice Bran Oil: Emerging Trends in Extraction, Health Benefit, and Its Industrial Application
Punia, S., Kumar, M., Siroha, A. K., & Purewal, S. S. (2021) · Rice Science · doi:10.1016/j.rsci.2021.04.002 · Cited by 158
“Inflammation may lead to angiogenesis, promoting cell proliferation and cell mobility (Mantovani et al, 2008).”
BackgroundCancer Associated Fibroblasts express pro-inflammatory factors in human breast and ovarian tumors
Erez, N., Glanz, S., Raz, Y., Avivi, C., & Barshack, I. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.06.089 · Cited by 167
NF-κB pathways in hematological malignancies
Gasparini, C., Celeghini, C., Monasta, L., & Zauli, G. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1545-4 · Cited by 166
“As well, the inflammatory process has proved to be an emerging enabling hallmark for cancer progression [2].”
Muzza, M., Degl’Innocenti, D., Colombo, C., Perrino, M., Ravasi, E., Rossi, S., Cirello, V., Beck‐Peccoz, P., Borrello, M. G., & Fugazzola, L. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03699.x · Cited by 171
Dual role of inflammatory mediators in cancer
Shrihari, T. (2017) · ecancermedicalscience · doi:10.3332/ecancer.2017.721 · Cited by 164
Massive APOBEC3 Editing of Hepatitis B Viral DNA in Cirrhosis
Vartanian, J.-P., Henry, M., Marchio, A., Suspène, R., Aynaud, M.-M., Guétard, D., Cervantes-Gonzalez, M., Battiston, C., Mazzaferro, V., Pineau, P., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000928 · Cited by 166
“As there is a long historical link between chronic inflammation and cancer [45,46], the ensemble suggested a link between aberrant AICDA expression”
BackgroundGarlanda, C., Anders, H.-J., & Mantovani, A. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.06.001 · Cited by 165
Self-citationPathophysiology of ocular surface squamous neoplasia
Gichuhi, S., Ohnuma, S.-I., Sagoo, M. S., & Burton, M. J. (2014) · Experimental Eye Research · doi:10.1016/j.exer.2014.10.015 · Cited by 161
“Inflammatory microenvironments have tumour-promoting effects (Mantovani et al., 2008).”
Aging, inflammation and cancer
Bottazzi, B., Riboli, E., & Mantovani, A. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.10.011 · Cited by 169
Self-citationDonadon, M., Torzilli, G., Cortese, N., Soldani, C., Tommaso, L. D., Franceschini, B., Carriero, R., Barbagallo, M., Rigamonti, A., Anselmo, A., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20191847 · Cited by 188
“Tumor-associated macrophages (TAMs), essential elements of the tumor microenvironment (Mantovani et al., 2008; Ruffell et al., 2012; Murray et al., 2014; Mantovani et al., 2017; DeNardo and Ruffell, 2019), pave the way to tissue invasion and intravasation and provide a nurturing microenvironment for metastasis, servin…”
Self-citationMusolino, C., Allegra, A., Innao, V., Allegra, A. G., Pioggia, G., & Gangemi, S. (2017) · Mediators of Inflammation · doi:10.1155/2017/1852517 · Cited by 168
Prognostic value of the neutrophil to lymphocyte ratio in lung cancer: A meta-analysis
Yin, Y., Wang, J., Wang, X., Gu, L., Pei, H., Kuai, S., Zhang, Y., & Shang, Z. (2015) · Clinics · doi:10.6061/clinics/2015(07)10 · Cited by 165
“Liao (35) 2013 China Asian 59 NSCLC M I-III NA 30 (8-40)”
BackgroundSerum IL-10 Predicts Worse Outcome in Cancer Patients: A Meta-Analysis
Zhao, S., Wu, D., Wu, P., Wang, Z., & Huang, J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0139598 · Cited by 164
“Cancer-related inflammation promotes the development and progression of tumor by different mechanisms, specifically by subverting immune response, inducing gene mutations, stimulating angiogenesis and cell proliferation and inhibiting apoptosis [5, 6].”
BackgroundMalignant cells fuel tumor growth by educating infiltrating leukocytes to produce the mitogen Gas6
Loges, S., Schmidt, T., Tjwa, M., van Geyte, K., Lievens, D., Lutgens, E., Vanhoutte, D., Borgel, D., Plaisance, S., Hoylaerts, M., et al. (2010) · Blood · doi:10.1182/blood-2009-06-228684 · Cited by 164
Coffee and cancer risk, epidemiological evidence, and molecular mechanisms
Bøhn, S. K., Blomhoff, R., & Paur, I. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300526 · Cited by 165
Gupta, J., del Barco Barrantes, I., Igea, A., Sakellariou, S., Pateras, I. S., Gorgoulis, V. G., & Nebreda, A. R. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.02.019 · Cited by 166
Chronotherapy and the molecular clock: Clinical implications in oncology☆
Innominato, P. F., Lévi, F. A., & Bjarnason, G. A. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.06.002 · Cited by 164
Oxidative Stress and Lectin-Like Ox-LDL-Receptor LOX-1 in Atherogenesis and Tumorigenesis
Lu, J., Mitra, S., Wang, X., Khaidakov, M., & Mehta, J. L. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3792 · Cited by 166
Autophagy in tumor suppression and cancer therapy
Kung, C.-P., Budina, A., Balaburski, G., Bergenstock, M. K., & Murphy, M. (2011) · Critical Reviews™ in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v21.i1.50 · Cited by 166
Irwin, M. R., Olmstead, R., Breen, E. C., Witarama, T., Carrillo, C., Sadeghi, N., Arevalo, J. M. G., Ma, J., Nicassio, P., Ganz, P. A., et al. (2014) · JNCI Monographs · doi:10.1093/jncimonographs/lgu028 · Cited by 160
PGE2 induced in and released by dying cells functions as an inhibitory DAMP
Hangai, S., Ao, T., Kimura, Y., Matsuki, K., Kawamura, T., Negishi, H., Nishio, J., Kodama, T., Taniguchi, T., & Yanai, H. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602023113 · Cited by 161
“Dysregulated and excessive inflammatory responses are linked to the initiation and/or exacerbation of a variety of diseases (1, 2).”
BackgroundO’Connor, M., Kellett, A., McCann, M., Rosair, G., McNamara, M., Howe, O., Creaven, B. S., McClean, S., Foltyn-Arfa Kia, A., O’Shea, D., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201041d · Cited by 170
Wu, T.-C., Xu, K., Martinek, J., Young, R. R., Banchereau, R., George, J., Turner, J., Kim, K. I., Zurawski, S., Wang, X., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0413 · Cited by 165
Ohashi, T., Akazawa, T., Aoki, M., Kuze, B., Mizuta, K., Ito, Y., & Inoue, N. (2013) · International Journal of Cancer · doi:10.1002/ijc.28114 · Cited by 164
Chang, Y., An, H., Xu, L., Zhu, Y., Yang, Y., Lin, Z., & Xu, J. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.241 · Cited by 165
Translational approaches to treatment-induced symptoms in cancer patients
Dantzer, R., Meagher, M. W., & Cleeland, C. S. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.88 · Cited by 161
Shinriki, S., Jono, H., Ota, K., Ueda, M., Kudo, M., Ota, T., Oike, Y., Endo, M., Ibusuki, M., Hiraki, A., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0287 · Cited by 163
Wang, J., Jia, Y., Wang, N., Zhang, X., Tan, B., Zhang, G., & Cheng, Y. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-7 · Cited by 166
“Discussion Inflammation seems to play a crucial role in cancer development by promoting or restraining progression, angiogenesis and metastasis, and impacting response to systemic therapies [20].”
BackgroundCurcumin, inflammation, ageing and age-related diseases
Sikora, E., Scapagnini, G., & Barbagallo, M. (2010) · Immunity & Ageing · doi:10.1186/1742-4933-7-1 · Cited by 164
“Epidemiological studies have shown that chronic inflammation predisposes individuals to various types of cancer [14].”
BackgroundGaines, S., Shao, C., Hyman, N., & Alverdy, J. C. (2018) · British Journal of Surgery · doi:10.1002/bjs.10760 · Cited by 163
Yang, L., Bao, T., Mo, J., Ni, J., & Chen, W. (2021) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2000594 · Cited by 183
Oh, J.-R., & Ahn, B. (2012) · Europe PMC (PubMed Central) · Cited by 166
Depression and Insomnia in Cancer: Prevalence, Risk Factors, and Effects on Cancer Outcomes
Irwin, M. R. (2013) · Current Psychiatry Reports · doi:10.1007/s11920-013-0404-1 · Cited by 165
“Moreover, given that certain cancers and their treatment also induce inflammation [34], the combined effects of sleep disturbance and cancer specific factors may work together to catalyze the onset of depression in cancer patients, particularly during the early interval after diagnosis and…”
Metastasis review: from bench to bedside
Alizadeh, A. M., Shiri, S., & Farsinejad, S. (2014) · Tumor Biology · doi:10.1007/s13277-014-2421-z · Cited by 160
NF-κB as a central regulator of macrophage function in tumors
Biswas, S. K., & Lewis, C. E. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0310153 · Cited by 161
“and CXCL12 (stromal cell-derived factor 1) [1, 6, 7], released”
BackgroundBarderas, R., Bartolomé, R. A., Fernandez-Aceñero, M. J., Torres, S., & Casal, J. I. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4090 · Cited by 163
“Chemokine-mediated inflammation has been shown to play an important role in tumor biology by influencing tumor growth, invasion, and metastasis (4).”
BackgroundThe role of CXCL12 in tumor microenvironment
Meng, W., Xue, S., & Chen, Y. (2018) · Gene · doi:10.1016/j.gene.2017.10.015 · Cited by 159
Jin, X., Moskophidis, D., & Mivechi, N. F. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.025 · Cited by 163
“In particular, inflammation through aberrant secretion of cytokines and chemokines and other progrowth factors supports proliferation and expansion of premalignant cells (Grivennikov et al., 2010; Mantovani et al., 2008).”
Wang, Y., Wang, K., Han, G.-C., Wang, R.-X., Xiao, H., Hou, C.-M., Guo, R.-F., Dou, Y., Shen, B.-F., Li, Y., et al. (2014) · Mucosal Immunology · doi:10.1038/mi.2013.126 · Cited by 163
“It is well established that chronic inflammation is a major driving force for tumor promotion and progression in many organs.(1) For instance, in patients with ulcerative colitis, one of the major forms of human chronic intestinal bowel disease, the risk of developing colorectal cancer is higher than in the general po…”
BackgroundMacrophage Infiltration Predicts a Poor Prognosis for Human Ewing Sarcoma
Fujiwara, T., Fukushi, J.-I., Yamamoto, S., Matsumoto, Y., Setsu, N., Oda, Y., Yamada, H., Okada, S., Watari, K., Ono, M., et al. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.05.034 · Cited by 164
Toll-Like Receptor 4 Activation in Cancer Progression and Therapy
Oblak, A., & Jerala, R. (2011) · Clinical and Developmental Immunology · doi:10.1155/2011/609579 · Cited by 175
Anti-cancer properties of low-molecular-weight heparin: Preclinical evidence
Petersen, L., & Mousa, S. (2009) · Thrombosis and Haemostasis · doi:10.1160/th08-12-0832 · Cited by 165
Inflammation, DNA methylation and colitis-associated cancer
Hartnett, L., & Egan, L. J. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs006 · Cited by 162
Metadata
- Authors
- Mantovani, A., Allavena, P., Sica, A., & Balkwill, F.
- Affiliations
- IRCCS Humanitas Research Hospital (IT)
- Fondazione Humanitas per la Ricerca (IT)
- Queen Mary University of London (GB)
- Venue
- Nature
- Published
- 2008-07-01
- Volume
- 454
- Issue
- 7203
- Pages
- 436-444
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2123105952
- Semantic Scholar
- b3a9e344a32ad6ca402d9149ac74b2b1df9e3076
- Cited by
- 11,399
- References
- 175
- Citations by year
- 2026: 419 · 2025: 554 · 2024: 655 · 2023: 761 · 2022: 848 · 2021: 878 · 2020: 864 · 2019: 759 · 2018: 752 · 2017: 732 · 2016: 692 · 2015: 683 · 2014: 643 · 2013: 574 · 2012: 510
- FWCI
- 26.32
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Funders
- Cancer Research UK
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Keywords
- tumor inflammation, tumor microenvironment, inflammatory mediators, angiogenesis, metastasis, immune evasion, chemoresistance, endocrine response, inflammatory signaling, therapeutic target
- MeSH terms
- Humans, Inflammation, Leukocytes, Neoplasm Invasiveness, Neoplasms, Oncogenes, Gonadal Steroid Hormones
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.